Podcasts about Cancer research

Partner with Jay: https://www.jayschwedelson.com/contactㅤPre-order Jay Schwedelson's new book, Stupider People Have Done It (out June 9, 2026).All net proceeds are donated to The V Foundation for Cancer Research, let's kick cancer's butt: https://www.amazon.com/Stupider-People-Have-Done-Marketing/dp/1637635206ㅤSubscribe to Jay's newsletter for weekly marketing tips and tactics: https://www.jayschwedelson.com/newsletterㅤRegister for Eventastic (FREE + VIRTUAL!) https://www.eventastic.comㅤRegister for GuruConference (FREE + VIRTUAL!) https://www.guruconference.comㅤConnect with Jay on LinkedIn: https://www.linkedin.com/in/schwedelson/Check out Jay's YouTube channel: https://www.youtube.com/@schwedelsonCheck out Jay's Instagram: https://www.instagram.com/jayschwedelson/Ask Jay anything: https://www.jayschwedelson.com/askㅤLeave a comment and follow the show, it really helps us out!ㅤBig shoutout to our sponsor, Knak!Marketers, you know the pain… You spend hours on a campaign, and then it gets stuck in review cycles and barely looks like what you started with.Knak makes it simple. Design emails and landing pages, collaborate, and launch - all in one place. No tool hopping, no messy handoffs, with AI built in to help you move faster.See how it all works, get started at knak.com/demoㅤThe link between ranking high on Google and getting cited in AI overviews has quietly fallen apart over the past year, and Jay Schwedelson has the numbers to prove just how fast. He lays out the small, almost boring tweaks that decide whether AI tools surface your content or skip right past it, then makes the case that your prettiest emails might be the ones working against you now. Stick around for a soccer confession and a book update with a genuinely good cause behind it.ㅤBest Moments:(00:42) Only 38% of pages cited in Google's AI overviews still rank in the top 10, down from 76% a year ago.(01:18) Put a date on everything you publish, because the AI tools are hunting hard for a recency signal.(02:15) Rewrite your headlines and page titles as questions so the LLMs actually pull them in.(03:33) Meltwater found 75% of LinkedIn AI citations come from personal profiles, not company pages.(05:33) Live text in the first 150 to 200 characters is becoming the new North Star for email.(09:14) His book hit number one new release on Amazon, with all proceeds going to cancer research.

At 25, Jace Yawnick was building a career in health and wellness sales, chasing growth, status, and the usual young adult fantasy of getting somewhere fast. Then his body stopped cooperating. Fatigue turned into chemotherapy. The diagnosis was primary mediastinal B cell non Hodgkin lymphoma, and the rest of his life split into before and after. Now in remission, he talks about cancer the way people actually live it, not the way nonprofits package it. He gets into survivorship, mental health, young adult isolation, and the deadening absurdity of prior authorization. One of the sharpest parts of the conversation lands on a simple American insult disguised as policy: treatment innovation means very little when insurance can still deny the scan, the drug, or the next step. Jace has seen that firsthand, including during routine monitoring after active treatment. This episode tracks what happens when a young cancer patient becomes a public voice and refuses to play mascot. It covers oncology, insurance, remission, advocacy, and the long mental hangover that follows survival. It also names the part too many institutions dodge: the system works great right up until it doesn't, and when it fails, patients get handed the bill, the panic, and a camera if they want anyone to care. RELATED LINKSJace Beats CancerJace Yawnick on LinkedImConquer Cancer ArticleCURE Today ArticlePyure BrandsFEEDBACKLike this episode? Rate and review Out of Patients on your favorite podcast platform. For guest suggestions or sponsorship email podcasts@matthewzachary.comSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Learn about the Healing Power of Prolonged Fasting: HEREWhat if one of the most studied alternative cancer therapies in the world was used across Europe and South America, yet still out of reach in the United States? Dr. Katie Deming sits down with Dr. Nasha Winters, a globally recognized authority in integrative oncology and co-author of Mistletoe and the Emerging Future of Integrative Oncology. Dr. Winters has trained hundreds of physicians in mistletoe therapy and has also used it herself.Together, they unpack a plant most people only know from the holidays and explore why injectable mistletoe has been used in cancer care since 1917. You'll hear how mistletoe may work on multiple levels: supporting the immune system, affecting the tumor environment, and helping the body's terrain during and after treatment.If you've ever felt rushed into decisions based on a scan, this episode is especially important. Dr. Winters explains pseudoprogression, a phenomenon where things may appear worse on imaging before they improve, and why timing scans too soon can lead to fear-driven decisions based on misleading information.Chapters:00:06:39 - The Most Studied Alternative Cancer Therapy00:08:18 - Why the U.S. Still Requires New Trials00:09:34 - The Patient Who Changed Dr. Winters' Path00:12:43 - How Mistletoe Works in the Body00:14:02 - Waking Up the Immune System00:16:28 - Quality of Life During Cancer Treatment00:18:42 - Mistletoe, Fasting, and Metabolic Support00:21:37 - Why Terrain Matters More Than Tumor Kill00:27:42 - Why Practitioner Training Matters00:30:01 - The Scan Mistake That Can Change Everything00:34:17 - When to Image During Mistletoe Therapy00:37:06 - When Healing Looks Worse Before Better00:41:00 - Who Should Be Careful With Mistletoe00:42:54 - Why Fasting and Mistletoe Work TogetherMost relevant support from the transcript: the episode moves from mistletoe's history and use since 1917, into mechanism and terrain, then closes with pseudoprogression, scan timing, and who should use caution. Stay until the end, because Dr. Winters shares how one patient first pushed her to explore mistletoe therapy, and how that moment opened the door to decades of clinical experience with a treatment most Americans still never hear about.Press play to learn why your body may be far more capable of healing than you've been told.Connect with Dr. Nasha: https://drnasha.com/Pick up a copy: Mistletoe and the Emerging Future of Integrative OncologyJoin Dr. Katie's 3-Day Guided Fast, for expert support, daily live calls, and a community to fast alongside: Sign-Up Follow Dr. Katie Deming on InstagramWatch on YoutubeDISCLAIMER: The Born to Heal Podcast  is intended for informational purposes only and is not a substitute for seeking professional medical advice, diagnosis, or treatment. Individual medical histories are unique; therefore, this episode should not be used to diagnose, treat, cure, or prevent any disease without consulting your healthcare provider.A thought-provoking podcast explores cancer through the lens of holistic medicine and functional medicine, discussing causes of cancer, metabolic health, and unconventional approaches like water fasting, fasting and autophagy, and detox, while weighing fasting benefits against chemo side effects and radiation side effects, sharing stories of a cancer survivor navigating chemotherapy, natural medicine, holistic healing, and even spiritual healing on the path toward cancer remission and holistic health. 

Stop trying to do it all. This Father's Day episode is your wake-up call—how to be the kind of dad, spouse, and leader who shows up when it matters. My special guest is Jay Bilas. You know Jay as one of ESPN's most trusted basketball voices. He joined ESPN in 1995 and has spent decades on the biggest stages in the sport, from College GameDay to the top men's college matchups every week, plus NBA Draft coverage and major studio shows. He is also the New York Times bestselling author of Toughness: Developing True Strength On and Off the Court. Jay was a four-year starter at Duke under Mike Krzyzewski from 1982 to 1986. His 1986 Duke team set the NCAA record for the most wins in a single season with 37. While Jay was an assistant coach under Krzyzewski, the Blue Devils won back-to-back National Championships in 1991 and 1992. Jay has also distinguished himself on Twitter, having been named to Sports Illustrated's “Twitter 100” for being among the 100 most essential Twitter follows in sports, and one of the 25 Most Powerful People in Sports Media by The Big Lead. Since 1992, Jay has been a licensed attorney with the law firm of Moore & Van Allen, PLLC, where he has specialized in commercial litigation. He serves on the National Board of the Coaches vs. Cancer Organization, the Board of Advisors of the Duke Brain Tumor Center, and the Board of Directors of The V Foundation for Cancer Research. This conversation isn't about basketball. It's about presence, priorities, and the quiet power of doing the right things when nobody's watching. In this episode, Jay gets real about: Why preparation is a form of toughness—and how it creates calm and confidence The trap of believing you can “have it all” (and what to do instead) The Father's Day truth that hits hard: what your family actually needs from you What kids remember most—and the simple standard that changes everything Jay's one-line job description for fathers: “Be there 100% when you're there.” This is your Father's Day wake-up call. Listen—and then make one change your family will feel this week. Follow Jay: @jbillis on X and Instagram.

Partner with Jay: https://www.jayschwedelson.com/contactㅤPre-order Jay Schwedelson's new book, Stupider People Have Done It (out June 9, 2026).All net proceeds are donated to The V Foundation for Cancer Research, let's kick cancer's butt: https://www.amazon.com/Stupider-People-Have-Done-Marketing/dp/1637635206ㅤSubscribe to Jay's newsletter for weekly marketing tips and tactics: https://www.jayschwedelson.com/newsletterㅤRegister for Eventastic (FREE + VIRTUAL!) https://www.eventastic.comㅤRegister for GuruConference (FREE + VIRTUAL!) https://www.guruconference.comㅤConnect with Jay on LinkedIn: https://www.linkedin.com/in/schwedelson/Check out Jay's YouTube channel: https://www.youtube.com/@schwedelsonCheck out Jay's Instagram: https://www.instagram.com/jayschwedelson/Ask Jay anything: https://www.jayschwedelson.com/askㅤLeave a comment and follow the show, it really helps us out!ㅤTurns out the fastest way to get over flinching at every bug at the dinner table is to suit up and stand in a cloud of fifty thousand bees, which is roughly the same energy Daniel Murray and Jay Schwedelson bring to email strategy. The real payoff here is a tactic most marketers are too nervous to run: hitting your database twice in a single day. Stick around for why the angry opt-outs are worth it, and the humbling reminder that almost nobody remembers your messaging as well as you think they do.ㅤFollow Daniel on LinkedIn and check out The Marketing Millennials podcast for sharp, no-fluff marketing insights. Subscribe to Ari Murray's newsletter at gotomillions.co for sharp, actionable marketing insights.ㅤBest Moments:(01:33) Jay suits up in a hazmat suit around 50,000 bees just to stop swatting at dinner(03:20) The aggressive play most people swear they could never run, two email sends to the same database in one day(04:15) Stacking urgency across two sends pushes conversions up more than thirty-five percent(06:33) A book launch nobody noticed, even the friend who follows everything Jay does(07:31) Why repeating the same message beats inventing a new one every time(08:27) When in doubt, send them out, and when in doubt, opt them out

The Golfweek Amateur Tour is about more than competition. It's about community, camaraderie, and making a difference. This week, Tim Newman and Chris Rocha welcome Arizona Tour Director Gabe Garcia and Assistant Director Jordan Isaac to discuss an ambitious nationwide fundraising campaign benefiting the V Foundation for Cancer Research. What began as a successful Arizona initiative is now expanding across the entire Golfweek Amateur Tour family, creating opportunities for players from every market to contribute to an important cause. Gabe and Jordan share details about the upcoming online auction featuring golf packages, stay-and-play experiences, and bucket-list golf destinations from across the country. They also discuss how every Golfweek Amateur Tour market can participate through creative fundraising efforts, 50/50 raffles, closest-to-the-pin contests, and member-driven initiatives. The conversation goes beyond fundraising as the group reflects on the impact cancer has had on members of the Golfweek Amateur Tour family, including the ongoing challenges faced by National Tour Director Dennis McCormac and his wife Jennifer. They also discuss plans to honor veterans, cancer survivors, and those we've lost by sharing their stories throughout the campaign. Later, Tim, Chris, Gabe, and Jordan share personal stories about golf, family, fathers, and the memories that keep bringing us back to the game. If you've ever wished for just one more round with someone special, this conversation will resonate. Plus: Arizona's nationwide V Foundation fundraising initiative How Golfweek Amateur Tour members can participate Upcoming online auction featuring golf packages from around the country Stories honoring veterans and cancer survivors Gabe's move to the Champ Flight Chris discusses another hole-in-one on the El Paso Tour Tim's love for the U.S. Open and why it's golf's greatest championship Memorable father-son golf stories Ryder Cup rivalry updates between Arizona and El Paso Whether you're a Golfweek Amateur Tour veteran, a first-time player, or simply a fan of Amateur Golf, this episode highlights what makes the Golfweek Amateur Tour such a special Golf Community. Where Amateurs Play Like Pros. For more information on the Golfweek Amateur Tour, visit:https://www.amateurgolftour.net For more information on the Senior Amateur Tour, visit:https://www.senioramateurgolftour.net Learn more about your ad choices. Visit megaphone.fm/adchoices

Partner with Jay: https://www.jayschwedelson.com/contactㅤPre-order Jay Schwedelson's new book, Stupider People Have Done It (out June 9, 2026).All net proceeds are donated to The V Foundation for Cancer Research, let's kick cancer's butt: https://www.amazon.com/Stupider-People-Have-Done-Marketing/dp/1637635206ㅤSubscribe to Jay's newsletter for weekly marketing tips and tactics: https://www.jayschwedelson.com/newsletterㅤRegister for Eventastic (FREE + VIRTUAL!) https://www.eventastic.comㅤRegister for GuruConference (FREE + VIRTUAL!) https://www.guruconference.comㅤConnect with Jay on LinkedIn: https://www.linkedin.com/in/schwedelson/Check out Jay's YouTube channel: https://www.youtube.com/@schwedelsonCheck out Jay's Instagram: https://www.instagram.com/jayschwedelson/Ask Jay anything: https://www.jayschwedelson.com/askㅤLeave a comment and follow the show, it really helps us out!ㅤConnect with Alexandra Conners on LinkedIn, and see what her team is building at wunderkind.co.ㅤEvery martech platform seems to be buying up every other one right now, each promising to become the single tool that finally does everything. Jay Schwedelson gets Alex Conners of Wunderkind to pressure-test that idea, and her take is refreshingly blunt: the all-in-one promise is mostly a mirage, and your real edge was never sitting in the stack to begin with. What she says is actually driving results now might change how you look at your next renewal.ㅤBest Moments:(02:20) Most brands use only about 30 percent of what their marketing tools can actually do(03:46) Why a platform's new acquisition is really just negotiation leverage with your CFO(06:04) The right martech pick has less to do with your industry than your team's skill set(07:17) Customer acquisition costs jumped 222 percent and the buying journey keeps getting longer(10:30) The average enterprise is quietly running 91 marketing tools, and the risk that creates(12:05) A plain-English breakdown of what Wunderkind actually does with your anonymous site visitors

At 20 years old, newly arrived from Puerto Rico and trying to build a future in science, Benjamin Suarez Jimenez found himself sitting in front of two senior faculty members accused of plagiarism. He knew the material. He had done the work. His mistake came from failing to cite class notes during an exam because nobody had told him that was expected. In a matter of minutes, he watched what felt like his entire career flash before him.On this episode of Standard Deviation, host Oliver Bogler examines the hidden architecture of academic science through the experiences of Dr. Benjamin Suarez Jimenez, Assistant Professor at the University of Rochester and a neuroscientist studying PTSD, anxiety, trauma, and spatial cognition through virtual reality and video game environments.Benjamin traces his path from Puerto Rico to the mainland United States, through the NIH, Columbia University, and eventually to leading his own laboratory. Along the way, he encountered a series of barriers that had little to do with scientific ability and everything to do with access to unwritten rules. From academic gatekeeping to grant writing expectations, he learned that success in biomedical research often depends on knowledge that never appears in a textbook.Oliver explores how those invisible obstacles shape careers, influence research funding, and determine who gains access to opportunity. The conversation also examines the Justice, Equity, Diversity, and Inclusion Program at the Life Science Editors Foundation, which pairs scientists from underrepresented backgrounds with experienced scientific editors. Through that mentorship, Benjamin transformed a critical grant proposal into a successful pilot award that helped launch an NIH R01 application.The discussion extends beyond one scientist's experience. Benjamin describes helping a former mentee navigate dissertation roadblocks that threatened her graduation, illustrating how institutional bureaucracy can delay careers and discourage talented researchers. Together, they explore the hidden administrative burden, cultural barriers, and bias that many scientists carry alongside their research, and what happens when someone who receives support turns around and opens the door for others.RELATED LINKSLife Science Editors FoundationBenjamin Suarez Jimenez LabDr. Benjamin Suarez JimenezBenjamin Suarez JimenezFEEDBACKLike this episode? Rate and review Out of Patients on your favorite podcast platform. For guest suggestions or sponsorship email podcasts@matthewzachary.comSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

A daily pill can double survival time in patients with the world's deadliest cancer, according to the results of a clinical trial that experts are saying is a gamechanger and one of the biggest breakthroughs in decades. To find out more about how daraxonrasib works and how life-changing it could be for patients, Madeleine Finlay speaks to Prof Naureen Starling, consultant medical oncologist at the Royal Marsden hospital. Help support our independent journalism at theguardian.com/sciencepod

Welcome to the Patient from Hell podcast! Live from ASCO 2026, we explore breakthroughs in clinical oncology, cancer research, AI healthcare tools, and targeted therapy for advanced cancer.Samira Daswani, Founder and CEO of Manta Cares and host of The Patient From Hell, sits down with Dr. Doug Blayney, Chief Medical Officer of Manta Cares and former ASCO President, for a candid debrief in between sessions at the 2026 ASCO Annual Meeting in Chicago.With 45,000 oncology professionals in attendance, ASCO is the largest gathering of cancer researchers and clinicians in the world. In this episode, Samira and Dr. Blayney break down what actually mattered: the clinical findings, the shifting treatment landscape, and what the research trends mean for patients navigating cancer today.This episode is for oncologists, cancer researchers, and anyone who wants to understand where the field is heading.Topics covered, with more to come in our next episode:Key clinical findings from ASCO 2026Trends shaping experimental and clinical oncologyWhat high attendance and collaboration signals for the future of cancer researchWhat patients should know coming out of this year's conferenceCHAPTERS:0:00 - ASCO 2026 Annual Meeting Live from Chicago0:27 - Artificial Intelligence (AI) in Oncology & Patient Experience1:19 - Healthcare AI Challenges: Misinformation & Clinician Deskilling2:03 - Pancreatic Cancer Breakthrough: New RAS/KRAS Targeted Therapy2:30 - Lung Cancer Advancements: ALK Mutations & PD-L1 Data3:01 - Breast Cancer Innovation: Oral SERDs & ESR1 Biomarkers3:41 - Next Episode Preview & Wrap UpSubscribe for frequent breakdowns of cancer research, treatment news, patient stories, and guidance and support for people in treatment for cancer. Drop a comment with the topics or trials you want us to cover next!

Partner with Jay: https://www.jayschwedelson.com/contactㅤPre-order Jay Schwedelson's new book, Stupider People Have Done It (out June 9, 2026).All net proceeds are donated to The V Foundation for Cancer Research, let's kick cancer's butt: https://www.amazon.com/Stupider-People-Have-Done-Marketing/dp/1637635206ㅤSubscribe to Jay's newsletter for weekly marketing tips and tactics: https://www.jayschwedelson.com/newsletterㅤRegister for Eventastic (FREE + VIRTUAL!) https://www.eventastic.comㅤRegister for GuruConference (FREE + VIRTUAL!) https://www.guruconference.comㅤConnect with Jay on LinkedIn: https://www.linkedin.com/in/schwedelson/Check out Jay's YouTube channel: https://www.youtube.com/@schwedelsonCheck out Jay's Instagram: https://www.instagram.com/jayschwedelson/Ask Jay anything: https://www.jayschwedelson.com/askㅤLeave a comment and follow the show, it really helps us out!ㅤTurns out one of the email "best practices" you have probably been told to follow for years might be quietly working against your list. Recording from the road this week, Jay Schwedelson makes the case that confirmed opt-in is more than halfway to dead, and that the spam-complaint logic everyone repeats about it is actually backward. If you have ever asked a new subscriber to click a confirmation link, this one is worth a few minutes.ㅤBest Moments:(00:33) LinkedIn rolled out free in-network versus out-of-network reach data on every post, no premium account required(02:00) Confirmed opt-in is fading fast, with usage down more than 45 percent year over year(03:33) The myth gets busted: lists built on double opt-in actually draw higher spam complaints, not fewer(04:15) Reddit just added video replies, opening a fresh way to reach its billion-plus monthly users(05:00) Jay's new book "Stupider People Have Done It" is out, with all author proceeds going to cancer research

Dr. Sarah Matt trained as a burn surgeon, working in a field where patients arrive with catastrophic injuries and survival depends on speed, skill, and resources. She left the bedside after confronting a limit that medicine does not like to admit. One physician can only see so many people in a day. The system surrounding those patients decides the rest. She moved into health technology, held leadership roles in startups, and built global infrastructure at Oracle to scale care across populations. Then she watched billions of dollars in digital health and AI initiatives stall out when they hit real clinical environments.This episode follows that pivot from surgeon to strategist and back into direct patient care in rural New York, where she now treats uninsured patients, migrant workers, and communities pushed to the margins. The conversation centers on a persistent failure across healthcare systems. Products get built for regulators, executives, and investors instead of the people who use them. The result shows up in failed adoption, broken workflows, prior authorization delays, and rising physician burnout.The discussion cuts through health policy language and lands on lived consequence. The system rewards speed over usability, scale over trust, and compliance over care. Patients absorb the fallout. Physicians carry the liability. The incentives remain intact.RELATED LINKSDr. Sarah MattThe Borderless Healthcare RevolutionThe Clinical RealistJessica FedererSovatoFEEDBACKLike this episode? Rate and review Out of Patients on your favorite podcast platform. For guest suggestions or sponsorship email podcasts@matthewzachary.comSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

In this episode of Game Over: c*ncer, hosts Dana Nichols and Val Solomon welcome Dr. Susan Weiner, founder of Children's Cancer Cause, pediatric cancer advocate, and national leader in childhood cancer policy.For more than 25 years, Dr. Weiner has worked alongside families, researchers, legislators, and advocacy organizations to improve childhood cancer treatment, survivorship care, pediatric drug development, and federal cancer research funding.This conversation explores the legislative victories that have transformed pediatric oncology, including the STAR Act, the RACE for Children Act, and efforts to improve survivorship resources for childhood cancer survivors. Dr. Weiner also shares how parents, survivors, and advocates can influence public policy and help secure funding for life-saving childhood cancer research.If you're interested in pediatric cancer research, childhood cancer advocacy, cancer survivorship, healthcare policy, rare disease research, clinical trials, federal research funding, or how families can create change, this episode is essential viewing.For more information on Children's Cancer Cause, visit https://www.childrenscancercause.org. There you will find many resources to help you get started including an advocacy toolkit.To view proposed pediatric cancer legislation, visit the Pediatric Cancer Action Network at https://www.pcanaction.org.At Cannonball Kids' cancer Foundation, we believe every child deserves access to better treatment options and a brighter future.Through research funding, education, and advocacy, we're working to accelerate progress in pediatric cancer.----------------------------------Connect with Dana: https://www.linkedin.com/in/danaknichols/Connect with Val: https://www.linkedin.com/in/valerie-solomon/Upcoming Ckc Events: https://cannonballkidscancer.org/category/make-an-impact/events/----------------------------------Podcast Produced by Hi Hello Labs: Website: https://www.hihellolabs.com/

Send us Fan MailS4E4 The Oncology Journal Club Podcast In this special ASCO 2026 edition of The Oncology Journal Club, Craig Underhill, Chris Jackson and Kate Clarke unpack some of the meeting's most talked-about studies and discuss what they could mean for clinical practice.From the PROTEUS trial in high-risk prostate cancer and promising advances in RET fusion-positive lung cancer, to a rare sarcoma study demonstrating the potential of CDK4 inhibition, the team explores the data behind the headlines and highlights the challenges of translating trial results into real-world care.The episode also dives into what many are calling the breakthrough study of the meeting – the RESOLUTE-302 trial of daraxonrasib in previously treated pancreatic cancer. With a striking overall survival benefit in a disease that has seen few meaningful advances, the results sparked excitement throughout the oncology community.Along the way, the panel reflects on the atmosphere at ASCO, emerging trends in precision oncology, and how new therapeutic approaches such as KRAS inhibitors, bispecific antibodies and antibody-drug conjugates are reshaping the future of cancer treatment.The Oncology Journal Club Podcast is hosted by Professor Craig Underhill, Dr Kate Clarke and Professor Chris Jackson, and proudly produced by The Oncology NetworkVisit oncologynetwork.com.au for Show Notes, to send us Voice Notes and more information. And to download your bingo card if you'd like to play along with the team!

Graffiti follow-up... Let's salute businesses or city efforts that beautify our communities (1:40); CONCERT ANNOUNCEMENT / Canada to ban social media for kids under 16 (8:40); Breakfast With The Bombers - Preparing for Thursday's home opener, and Chris Streveler will be our co-host on Thursday??? (16:00); City of Winnipeg on graffiti and flowers (25:25); World Cup at work: How employers can turn tournament fever into engagement gains (33:05); Minitonas flooding update after torrential rain (43:00); Winning entries on saluting the efforts to beautify our communities (49:50); Swan River update... roads washed out everywhere / JONNY'S BIG SWIM... Swimming across Lake Winnipeg to raise fund for Cancer Research (53:50).

This week on High on Home Grown, we cover a mix of international cannabis law, medical research, and major policy developments that could shape the future of the industry. Macky:  Australian woman faces jail time over alleged cannabis vape liquid in Indonesia - ABC News  Smee: Medical Cannabis Driving Rules UK | 2026 Guide Dr.Margaret: Vertanical Secures FDA Breakthrough Designation for Cannabis-Based Pain Drug  Billy: In oncological research, A new meta-analysis has systematically evaluated that anti-tumor effects are observed with THC/CBD use.  John: White House Pushes Congress To Keep Hemp CBD Products Legal By Amending Broad Ban That's Set To Take Effect Later This Year In this week's discussion, we look at the severe legal risks cannabis consumers face when travelling internationally, including the case of an Australian woman facing prison time in Indonesia over alleged cannabis vape liquid possession. We also take a detailed look at the UK's medical cannabis driving rules, discussing what patients need to know to stay compliant and protect themselves legally. On the medical front, we cover a major milestone as Vertanical receives FDA Breakthrough Therapy designation for a cannabis-based pain treatment, while new cancer research continues to explore the anti-tumour potential of THC and CBD. Finally, we discuss growing political support in the United States to keep hemp-derived CBD products legal, as lawmakers and the White House work to prevent a broad ban that could impact businesses and consumers across the country. Another packed episode covering science, law, medicine, and the ever-changing cannabis landscape around the world.

Partner with Jay: https://www.jayschwedelson.com/contactㅤPre-order Jay Schwedelson's new book, Stupider People Have Done It (out June 9, 2026).All net proceeds are donated to The V Foundation for Cancer Research, let's kick cancer's butt: https://www.amazon.com/Stupider-People-Have-Done-Marketing/dp/1637635206ㅤSubscribe to Jay's newsletter for weekly marketing tips and tactics: https://www.jayschwedelson.com/newsletterㅤRegister for Eventastic (FREE + VIRTUAL!) https://www.eventastic.comㅤRegister for GuruConference (FREE + VIRTUAL!) https://www.guruconference.comㅤConnect with Jay on LinkedIn: https://www.linkedin.com/in/schwedelson/Check out Jay's YouTube channel: https://www.youtube.com/@schwedelsonCheck out Jay's Instagram: https://www.instagram.com/jayschwedelson/Ask Jay anything: https://www.jayschwedelson.com/askㅤLeave a comment and follow the show, it really helps us out!ㅤMost of us figure we've already tried every subject line trick worth trying, which is exactly what makes this batch so annoying. Jay Schwedelson runs through a pile of tactics that sound too dumb to work, like dropping a period after every word or dressing up a subject line as a calendar invite, except the open rates keep climbing anyway. Stick around for the strangely strong hill he's willing to die on involving coworkers, swimming pools, and dance floors.ㅤBest Moments:(01:20) Why a subject line that reads like a calendar invite is lifting opens by 28%.(02:15) The bracketed newsletter trick everyone abandoned, back from the dead and working again.(03:43) Opening a subject line with And or But to trigger a different kind of curiosity.(04:15) A period. After. Every. Word. And the quiet drama it stirs up.(04:46) Dropping next month into your subject line two weeks early, and why people bite.(06:00) Jay's deeply held refusal to see work people in bathing suits or on a dance floor.

Donations made through the "More Than 4 Challenge" go directly toward funding research and raising awareness for childhood cancer — a cause that receives only 4% of federal cancer research funding despite being the leading cause of disease-related death among children. https://www.pledge.to/mt4zoesgoal with $4 donation. Zoe's Goal City: Beverly Hills Address: 133 N Almont Dr, #301 Website: https://zoesgoal.org/ Phone: +1 602 487 1546 Email: leslie@zoesgoal.org

In this special National Cancer Survivor Month episode of Navigating Cancer TOGETHER, host and 15-year cancer thriver Talaya Dendy brings together seven survivors at different stages of their journey to explore what survivorship truly means. From newly diagnosed to 20 years out, Vanessa, Shoni, Savio, Jerry, Ebonie, Christopher, and Heather share their challenges, unexpected blessings, and the raw, unfiltered truth about life after a cancer diagnosis. Together, they redefine what it means to truly live. Whether you are a survivor, a caregiver, or someone who loves a person carrying this story, this episode is for you.✨ Episode Highlights:00:00:37 What Does It Mean to Be a Cancer Survivor?00:02:26 The Growing Number of Survivors and Why It Matters00:04:09 The Physical, Emotional, and Financial Challenges of Survivorship00:09:00 Vanessa Berrueta | Breast Cancer Survivor | Adapting Like a Butterfly00:13:55 Shoni Brown | 10-Year Breast Cancer Survivor | Going Through It, Not Around It00:31:22 Savio Clemente | Non-Hodgkin's Lymphoma Survivor | Permission to Heal00:37:58 Jerry McCormick | Prostate Cancer Survivor | It's a Bump, Not a Pothole00:51:47 Ebonie Michelle | Bilateral Breast Cancer Survivor | Thrivership Over Survivorship01:03:04 Christopher Shaddock | Stage 4 Prostate Cancer Survivor | Big Boy Pants On01:14:01 Heather Von St. James | 20-Year Mesothelioma Survivor | Speaking for Those Who No Longer Can01:18:34 Closing | What If You Were Always Becoming This?Transcript: https://bit.ly/podscript182

Partner with Jay: https://www.jayschwedelson.com/contactㅤPre-order Jay Schwedelson's new book, Stupider People Have Done It (out June 9, 2026).All net proceeds are donated to The V Foundation for Cancer Research, let's kick cancer's butt: https://www.amazon.com/Stupider-People-Have-Done-Marketing/dp/1637635206ㅤSubscribe to Jay's newsletter for weekly marketing tips and tactics: https://www.jayschwedelson.com/newsletterㅤRegister for Eventastic (FREE + VIRTUAL!) https://www.eventastic.comㅤRegister for GuruConference (FREE + VIRTUAL!) https://www.guruconference.comㅤConnect with Jay on LinkedIn: https://www.linkedin.com/in/schwedelson/Check out Jay's YouTube channel: https://www.youtube.com/@schwedelsonCheck out Jay's Instagram: https://www.instagram.com/jayschwedelson/Ask Jay anything: https://www.jayschwedelson.com/askㅤLeave a comment and follow the show, it really helps us out!ㅤEver asked an AI tool to explain your own company and cringed at how wrong it got things? This week there's a genuinely simple fix for that, and Jay Schwedelson lays it out in a way that turns those AI answers into a ready-made content plan. He somehow gets there by way of a hospital collab and a four-dollar Instagram upgrade he's weirdly excited about, which tells you everything about how this one flows.ㅤBest Moments:(00:16) Disney teams up with Philips to surround kids with ambient Disney characters during their MRIs(01:36) The gut-punch stat, 88 percent of CMOs are getting grilled on AI visibility while most have no plan(02:06) Most marketers have already caught AI describing their company completely wrong(03:40) Ask all four AI tools the same question, then build content around the answers they all share(04:52) Meta's new Instagram add-on lets your stories outlive the 24-hour cutoff, and Jay thinks it's worth it(06:45) The Eventastic pitch arrives with DJs, a cannonball guy, and a Taylor Swift dance contest

In the late 1980s, a child exposed to fallout from the Chernobyl disaster lay in a hospital bed while doctors told his family there were no clear answers and no reliable path forward. Decades later, that same child, Yan Leyfman, walks into exam rooms as a hematology oncology fellow, expected to deliver clarity inside a system that still runs on delay, uncertainty, and institutional self preservation.This episode traces the throughline from early life shaped by radiation exposure and hospice level uncertainty to a career inside academic medicine, translational research, and oncology media. Yan built his identity around survival and usefulness, moving from patient to physician while carrying the memory of what it feels like to sit on the other side of the table. He helped launch MedNews Week during the COVID crisis to push back on misinformation and expand access to medical knowledge, stepping into a public role while still in training.The conversation stays grounded in the friction between personal narrative and system reality. Clinical training demands efficiency, hierarchy, and emotional distance. Cancer care demands time, clarity, and human connection. Those forces collide in real patient encounters where prior authorization delays, insurance barriers, and fragmented care pathways shape outcomes as much as any treatment protocol.Yan speaks openly about mentorship, belonging, and the drive to make meaning out of survival. The discussion pushes further into what the healthcare system actually rewards, what it quietly strips away, and how quickly empathy can erode under institutional pressure. The episode also examines the role of medical media, where education, industry influence, and narrative control often blur together.This is a conversation about identity under construction, about what happens when someone who remembers powerlessness steps into a role that carries authority, and about whether that memory can survive long enough to change anything.RELATED LINKSYan Leyfman on LinkedInYan Leyfman on InstagramSurviving ChernobylFEEDBACKLike this episode? Rate and review Out of Patients on your favorite podcast platform. For guest suggestions or sponsorship email podcasts@matthewzachary.comSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Partner with Jay: https://www.jayschwedelson.com/contactㅤPre-order Jay Schwedelson's new book, Stupider People Have Done It (out June 9, 2026).All net proceeds are donated to The V Foundation for Cancer Research, let's kick cancer's butt: https://www.amazon.com/Stupider-People-Have-Done-Marketing/dp/1637635206ㅤSubscribe to Jay's newsletter for weekly marketing tips and tactics: https://www.jayschwedelson.com/newsletterㅤRegister for Eventastic (FREE + VIRTUAL!) https://www.eventastic.comㅤRegister for GuruConference (FREE + VIRTUAL!) https://www.guruconference.comㅤConnect with Jay on LinkedIn: https://www.linkedin.com/in/schwedelson/Check out Jay's YouTube channel: https://www.youtube.com/@schwedelsonCheck out Jay's Instagram: https://www.instagram.com/jayschwedelson/Ask Jay anything: https://www.jayschwedelson.com/askㅤLeave a comment and follow the show, it really helps us out!ㅤEver caught yourself snapping at ChatGPT when it just won't get something right? Jay Schwedelson and Daniel Murray get into exactly how (un)kind they are to their AI tools, then swing into the small webinar habits quietly tanking everyone's show-up rates. It's equal parts petty and practical, and the live-only advice alone earns the ten minutes.ㅤFollow Daniel on LinkedIn and check out The Marketing Millennials podcast for sharp, no-fluff marketing insights. Subscribe to Ari Murray's newsletter at gotomillions.co for sharp, actionable marketing insights.ㅤBest Moments:(01:53) Jay confesses he's relentlessly rude to AI and explains why yelling never actually helps(02:47) The hidden environmental cost of being polite to ChatGPT(03:48) The webinar title mistake that kills curiosity before anyone signs up(06:51) Why a serialized, same-time webinar turns it into a show people come back to(07:16) Two day-of reminder emails and the 400% jump that comes from live attendanceㅤ(09:06) Holding on-demand hostage for 30 days to force people to show up live

Partner with Jay: https://www.jayschwedelson.com/contactㅤPre-order Jay Schwedelson's new book, Stupider People Have Done It (out June 9, 2026).All net proceeds are donated to The V Foundation for Cancer Research, let's kick cancer's butt: https://www.amazon.com/Stupider-People-Have-Done-Marketing/dp/1637635206ㅤSubscribe to Jay's newsletter for weekly marketing tips and tactics: https://www.jayschwedelson.com/newsletterㅤRegister for Eventastic (FREE + VIRTUAL!) https://www.eventastic.comㅤRegister for GuruConference (FREE + VIRTUAL!) https://www.guruconference.comㅤConnect with Jay on LinkedIn: https://www.linkedin.com/in/schwedelson/Check out Jay's YouTube channel: https://www.youtube.com/@schwedelsonCheck out Jay's Instagram: https://www.instagram.com/jayschwedelson/Ask Jay anything: https://www.jayschwedelson.com/askㅤLeave a comment and follow the show, it really helps us out!ㅤConnect with Kristen on LinkedIn and visit ringcentral.com to see what they're building with AI across voice, video, and messaging.ㅤMost marketers are using AI to shout louder. Kristen Koenig, who leads AI and Collaboration go-to-market at RingCentral, thinks the smarter move is using it to listen better. She's back with Jay Schwedelson to unpack what most marketers are getting wrong about AI, why voice is having a renaissance, and what meetings will actually feel like three years from now.ㅤBest Moments:(01:46) Why right now is a renaissance moment for marketers and communicators(02:39) The fix for AI that sounds like a robot starts with feeding it your real voice(04:35) The biggest thing most marketers are getting wrong with AI(06:49) More content, worse quality, and why chasing volume is a trap(11:43) Why companies are so AI-obsessed, they're forgetting to improve the actual mothership product(13:39) What voice and video will actually feel like in the next three years

Matthew Zachary is a brain cancer survivor, healthcare advocate, founder of Stupid Cancer and We the Patients, and host of Out of Patients. In April 2026, he returned to the stage at Merkin Hall near Lincoln Center for his first solo public piano concert in almost 22 years while launching his debut book, We the Patients: Understanding, Navigating, and Surviving America's Healthcare Nightmare.What unfolded became far larger than a concert.Over 2 hours, survivors, clinicians, advocates, nonprofit founders, journalists, pharmaceutical sponsors, and healthcare insiders gathered in one room to reflect on 30 years of survivorship, institutional failure, accidental advocacy, and the emotional afterlife of cancer. The evening moved through original piano performances, live chapter readings, and deeply personal conversations about infertility, disability, financial toxicity, insurance denials, grief, burnout, and what happens when patients spend decades navigating systems designed around transactions instead of continuity.Guests including Wendell Potter, Maimah Karmo, Craig Lustig, Shelly Fuld Nasso, Tamika Felder, and others reflected on how the modern cancer advocacy movement emerged largely because patients built parallel systems where healthcare infrastructure failed to meet human needs. The conversation explored how prior authorization, reimbursement incentives, administrative fragmentation, and institutional distrust continue shaping the patient experience across oncology and survivorship.The performance also marked a deeply personal milestone. After brain cancer compromised his left hand at age 21, Zachary spent 6 months rehabilitating both hands to return to public performance for the first time in over 2 decades. The result became part concert, part civic gathering, and part historical record of a generation of survivors who refused to disappear quietly.RELATED LINKSMZLIVE Official WebsiteMZLIVE YouTube VideoFEEDBACKLike this episode? Rate and review Out of Patients on your favorite podcast platform. For guest suggestions or sponsorship email podcasts@matthewzachary.comSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Partner with Jay: https://www.jayschwedelson.com/contactㅤPre-order Jay Schwedelson's new book, Stupider People Have Done It (out June 9, 2026).All net proceeds are donated to The V Foundation for Cancer Research, let's kick cancer's butt: https://www.amazon.com/Stupider-People-Have-Done-Marketing/dp/1637635206ㅤSubscribe to Jay's newsletter for weekly marketing tips and tactics: https://www.jayschwedelson.com/newsletterㅤRegister for Eventastic (FREE + VIRTUAL!) https://www.eventastic.comㅤRegister for GuruConference (FREE + VIRTUAL!) https://www.guruconference.comㅤConnect with Jay on LinkedIn: https://www.linkedin.com/in/schwedelson/Check out Jay's YouTube channel: https://www.youtube.com/@schwedelsonCheck out Jay's Instagram: https://www.instagram.com/jayschwedelson/Ask Jay anything: https://www.jayschwedelson.com/askㅤLeave a comment and follow the show, it really helps us out!ㅤEver wonder why your slick, AI-polished marketing content gets crickets while someone's shaky phone clip from a hallway racks up engagement? Jay Schwedelson breaks down the lo-fi content formats actually winning right now, with hard numbers on why behind-the-scenes videos, walking selfies, and even airport rants outperform the polished stuff. Stick around for the chaos of prepping Eventastic, which somehow involves a Taylor Swift impersonator, a mouth guard game, and a guy being shot out of a cannon.ㅤBest Moments:(00:16) Why expensive, AI-perfect marketing now reads as more boring than wallpaper(01:30) Behind-the-scenes video drives 200% higher engagement on LinkedIn than any other format(02:45) The red play button trick that lifts email click-through rates by 34%(03:30) Walking selfies pull 49% higher completion on LinkedIn and 57% on Instagram(04:14) Desk drive-bys and one-take mistake clips that beat any polished asset(05:15) Why airport walk-and-talks turn boring B2B content into something humans actually watch(06:30) The behind-the-scenes panic of dry-running the Fate of Ophelia dance for Eventastic

Partner with Jay: https://www.jayschwedelson.com/contactㅤPre-order Jay Schwedelson's new book, Stupider People Have Done It (out June 9, 2026).All net proceeds are donated to The V Foundation for Cancer Research, let's kick cancer's butt: https://www.amazon.com/Stupider-People-Have-Done-Marketing/dp/1637635206ㅤSubscribe to Jay's newsletter for weekly marketing tips and tactics: https://www.jayschwedelson.com/newsletterㅤRegister for Eventastic (FREE + VIRTUAL!) https://www.eventastic.comㅤRegister for GuruConference (FREE + VIRTUAL!) https://www.guruconference.comㅤConnect with Jay on LinkedIn: https://www.linkedin.com/in/schwedelson/Check out Jay's YouTube channel: https://www.youtube.com/@schwedelsonCheck out Jay's Instagram: https://www.instagram.com/jayschwedelson/Ask Jay anything: https://www.jayschwedelson.com/askㅤLeave a comment and follow the show, it really helps us out!ㅤMASSIVE thank you to our Sponsor, CallRail!CallRail is the AI-powered lead intelligence platform that helps marketers prove exactly what's driving results. With CallRail, you can connect every call, text, chat, and form submission directly to the campaign that generated it so you finally know what's working and where to double down.Plus, with built-in AI conversation intelligence, CallRail analyzes your customer conversations, captures leads 24/7, and gives you deeper insights into what your prospects actually care about.If you're tired of guessing about your marketing ROI and want real data behind your campaigns, CallRail has you covered.Start a Free Trial Here: https://www.callrail.com/dothisㅤMeta just quietly dropped a standalone app built to swipe users straight from Reddit, and that's only the start of what Jay Schwedelson is digging into this week. There's also a new LinkedIn tool that exposes which AI models people are actually using by industry, plus some fresh data showing that one tiny tweak to your promotional emails can triple engagement and seriously boost your inbox placement.ㅤBest Moments:(00:16) Meta launches Forum, a standalone app built to go straight at Reddit(01:36) LinkedIn Cross Check reveals which AI models are dominating by industry(03:30) Why reply-driven promotional emails are pulling 3X the engagement(04:25) The 90-day inbox placement lift B2B brands are seeing from reply CTAs(05:18) Reply rate is now the number one signal for Outlook, Gmail, and Yahoo(06:30) Love Island USA returns June 2nd with ad demand up 73% year over year

In December 1996, a 37 year old pharmaceutical executive sat in a Borders bookstore reading medical textbooks on the floor, trying to understand a disease she had never heard of. Multiple myeloma carried a three year prognosis. Her daughter was 18 months old. Her father had just died of cancer. Within weeks, she pushed her doctors to say the quiet part clearly. This would likely end her life before her child entered kindergarten.Kathy Giusti refused to accept passive survival. She built a plan while the system offered fragments. She interviewed oncologists and fertility specialists at the same time. She pursued IVF to have a second child while preparing for treatment. She stayed employed to keep insurance coverage. Every decision carried financial, medical, and emotional risk.That same urgency exposed a deeper failure. Cancer research moved slowly. Academic centers guarded data. Clinical trials lacked coordination. Patients entered a system that demanded compliance without providing clarity. Giusti responded by building the Multiple Myeloma Research Foundation, not as a support group, but as an operating engine to accelerate drug development, fund research, and force collaboration across institutions.This episode tracks the tension between individual agency and systemic failure. Giusti describes how patients navigate diagnosis, insurance barriers, and fragmented care in real time. She explains how data, genomics, and clinical trials reshape cancer treatment while still leaving patients responsible for decisions they are not trained to make. She addresses disparities in access, the limits of early detection, and the reality that progress in oncology often depends on speed, funding, and alignment of incentives.The conversation moves between lived experience and structural critique. It names the cost of delay, the burden placed on patients to act as their own advocate, and the tradeoffs required to push a system forward that still protects itself first.⸻RELATED LINKSKathy GiustiMultiple Myeloma Research FoundationFatal to FearlessAmerican Society of Hematology⸻FEEDBACKLike this episode? Rate and review Out of Patients on your favorite podcast platform. For guest suggestions or sponsorship email podcasts@matthewzachary.comSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Why is pediatric brain cancer research so underfunded, and what does it actually take to build breakthroughs for children fighting cancer?In this episode of Game Over: c*ncer, Val Solomon and Dana Nichols sit down with Dr. John Prensner, pediatric neuro-oncologist, researcher, and Assistant Professor of Pediatrics at the University of Michigan Medical School. As the recipient of the 2025 Young Investigator Grant from Cannonball Kids' cancer Foundation, Dr. Prensner is leading groundbreaking research focused on relapsed medulloblastoma, DIPG, ATRT, and the molecular drivers behind pediatric brain tumors.Dr. Prensner shares the deeply personal story that inspired him to pursue pediatric cancer research after encountering a young mother dying of brain cancer during his early hospital experiences. The conversation explores the emotional realities of pediatric oncology, the importance of mentorship in science, and how collaboration between labs, institutions, and researchers across the world is accelerating innovation for children with cancer.This episode also dives into the growing concerns surrounding pediatric cancer funding, NIH research grants, instability in federal funding, and the long-term effects these challenges have on the future pipeline of childhood cancer researchers and scientific breakthroughs.If you care about advancing pediatric cancer research, supporting innovative treatments, and learning how researchers are working to change outcomes for children battling cancer, this episode is for you.----------------------------------Connect with Dana: https://www.linkedin.com/in/danaknichols/Connect with Val: https://www.linkedin.com/in/valerie-solomon/Upcoming Ckc Events: https://cannonballkidscancer.org/category/make-an-impact/events/----------------------------------Podcast Produced by Hi Hello Labs: Website: https://www.hihellolabs.com/

Partner with Jay: https://www.jayschwedelson.com/contactㅤPre-order Jay Schwedelson's new book, Stupider People Have Done It (out June 9, 2026).All net proceeds are donated to The V Foundation for Cancer Research, let's kick cancer's butt: https://www.amazon.com/Stupider-People-Have-Done-Marketing/dp/1637635206ㅤSubscribe to Jay's newsletter for weekly marketing tips and tactics: https://www.jayschwedelson.com/newsletterㅤRegister for Eventastic (FREE + VIRTUAL!) https://www.eventastic.comㅤRegister for GuruConference (FREE + VIRTUAL!) https://www.guruconference.comㅤConnect with Jay on LinkedIn: https://www.linkedin.com/in/schwedelson/Check out Jay's YouTube channel: https://www.youtube.com/@schwedelsonCheck out Jay's Instagram: https://www.instagram.com/jayschwedelson/Ask Jay anything: https://www.jayschwedelson.com/askㅤLeave a comment and follow the show, it really helps us out!ㅤMemorial Day weekend brings up the eternal marketer's debate: do you keep the emails flowing or pump the brakes for the holiday? Jay Schwedelson and Daniel Murray make a strong case for sticking with consistency, plus share a surprisingly clever trick for turning all those out-of-office auto replies into retargeting fuel. Stick around for a housewarming gift confession that'll either make you laugh or quietly question your own friendships.ㅤFollow Daniel on LinkedIn and check out The Marketing Millennials podcast for sharp, no-fluff marketing insights. Subscribe to Ari Murray's newsletter at gotomillions.co for sharp, actionable marketing insights.ㅤBest Moments:(01:46) The Irish goodbye strategy for surviving networking events you didn't want to attend(02:49) Why breaking consistency for a holiday is a bigger mistake than the lost opens(03:47) Turning out-of-office auto replies into a retargeting goldmine with one AI tool(05:38) The subject line trick for speaking to the exact moment your audience is living in(08:34) How LinkedIn's new 24 to 48 hour algorithm window is changing what a "flop post" looks like(10:37) The unopened housewarming gift sitting on a counter for six months that says everything about adult friendships

Partner with Jay! https://www.jayschwedelson.com/contactㅤPre-order Jay Schwedelson's new book, Stupider People Have Done It (out June 9, 2026). All net proceeds are donated to The V Foundation for Cancer Research—let's kick cancer's butt: https://www.amazon.com/Stupider-People-Have-Done-Marketing/dp/1637635206ㅤCheck out Jay's YOUTUBE Channel: https://www.youtube.com/@schwedelsonCheck out Jay's TIKTOK: https://www.tiktok.com/@schwedelsonCheck Out Jay's INSTAGRAM: https://www.instagram.com/jayschwedelson/ㅤConnect with Laura Morton on LinkedIn and explore Lasega Books at lasegabooks.com to learn about her hybrid publishing imprint.ㅤImagine writing your first book, hitting a wall, and then learning the person guiding you through it has 23 New York Times bestsellers on her shelf and 60-plus titles with names like Justin Bieber, the Jonas Brothers, and Al Roker.ㅤThat's the call Jay Schwedelson made when he started writing Stupider People Have Done It, and the person he kept hearing about was Laura Morton.ㅤShe's the publisher behind his book, the founder of Lasega Books, and she joins to pull back the curtain on what really sells, what AI can't fake, and why pre-orders quietly decide everything.ㅤBest Moments:(02:45) Four million books were published last year, and the average one sells just 300 copies(06:00) The three boxes a book has to check before Laura agrees to publish it(07:05) Why even billionaire founders walk in feeling like total impostors(09:38) How Laura spots an AI-written manuscript in under a minute(14:30) The word "intimacy" broken down into "into me you see," and why that's what readers really come for(17:00) The real reason pre-orders matter more than the launch week itself(22:15) Writing the book is only ten percent of the work, the other ninety is what most authors miss

Partner with Jay! https://www.jayschwedelson.com/contactㅤPre-order Jay Schwedelson's new book, Stupider People Have Done It (out June 9, 2026). All net proceeds are donated to The V Foundation for Cancer Research—let's kick cancer's butt: https://www.amazon.com/Stupider-People-Have-Done-Marketing/dp/1637635206ㅤCheck out Jay's YOUTUBE Channel: https://www.youtube.com/@schwedelsonCheck out Jay's TIKTOK: https://www.tiktok.com/@schwedelsonCheck Out Jay's INSTAGRAM: https://www.instagram.com/jayschwedelson/ㅤMost people use AI to spit out a blog post and call it a day, but Jay Schwedelson thinks that's leaving the good stuff on the table. He shares a few sneaky free-tier tricks that pull back the curtain on your competitors' martech stacks, make AI tools quote your brand back to searchers, and even predict which emails in your inbox will get opened. Then things go fully off the rails into reality TV territory.ㅤBest Moments:(01:20) The Ask Gemini button hiding in your Chrome browser that exposes any competitor's full martech stack(03:14) Why comparison tables are the number one piece of content AI engines hunt for when answering queries(04:14) A ChatGPT prompt that builds a competitive comparison table skewed in your favor without lying(05:11) Uploading a screenshot of your analytics dashboard so AI can tell you what to actually do with it(06:00) The cheesy inbox screenshot trick that ranks which emails are most and least likely to be opened(07:30) Why Send Help is not the horror movie everyone thinks it is, plus the most bonkers reality show on TV right now

Partner with Jay! https://www.jayschwedelson.com/contactㅤPre-order Jay Schwedelson's new book, Stupider People Have Done It (out June 9, 2026). All net proceeds are donated to The V Foundation for Cancer Research—let's kick cancer's butt: https://www.amazon.com/Stupider-People-Have-Done-Marketing/dp/1637635206ㅤCheck out Jay's YOUTUBE Channel: https://www.youtube.com/@schwedelsonCheck out Jay's TIKTOK: https://www.tiktok.com/@schwedelsonCheck Out Jay's INSTAGRAM: https://www.instagram.com/jayschwedelson/ㅤBig shoutout to our sponsor, Knak!Marketers, you know the pain… You spend hours on a campaign, and then it gets stuck in review cycles and barely looks like what you started with.Knak makes it simple. Design emails and landing pages, collaborate, and launch - all in one place. No tool hopping, no messy handoffs, with AI built in to help you move faster.See how it all works, get started at knak.com/demoㅤFriday used to be the day no one bothered sending emails, and now it's quietly become one of the two best days of the week, with Jay Schwedelson walking through fresh numbers from a 26 billion email study to prove it. There's also a quick read on how Alexa Plus is changing the way Amazon shoppers find products, why use case copy is suddenly the most valuable thing you can put on a landing page, and a real talk on which days webinars actually show up. Plus a Spotify logo panic that says a lot about how we're all doing.ㅤBest Moments:(00:16) Omnisend pulled apart 26 billion emails and Friday quietly climbed into the top two send days of the week(01:25) Sunday's 11 AM window delivers a 33.69 percent open rate, one of the strongest stretches anywhere in the week(02:00) Spotify swapped its logo for a disco ball and the internet briefly lost its collective mind over an app icon(02:34) Alexa Plus is rolling out across Amazon and use case copy like "best for" and "ideal if" is the new language AI shopping assistants reward(03:54) Year over year webinar show-up rates on Fridays jumped from 27 to 35 percent, with Mondays sliding the other direction(07:30) The book launches June 9th with all net author proceeds going to the V Foundation for Cancer Research

At 19, Shlomit woke up unable to speak. The right side of her body went numb. An emergency room sent her home and called it stress. That moment did not end in a diagnosis that changed policy or triggered reform. It sent her into a decade long pursuit of understanding how the brain fails language and how the healthcare system fails patients who cannot advocate for themselves.Shlomit trained as a speech language pathologist and spent years inside acute care hospitals and ICUs, performing endoscopies and treating patients with brain injury, stroke, and dysphagia. She watched medical teams rotate in and out, deliver dense updates, and leave families nodding without comprehension. She stayed behind and translated. Every day, patients told her she was the only one who explained what was happening. That gap is not an accident. Hospital systems optimize for throughput, not understanding. Patients move through beds based on cost, not readiness. Discharge planning becomes a financial decision wrapped in clinical language. A stay under 48 hours can shift the insurance burden dramatically, leaving patients exposed to higher out of pocket costs. Shlomit left the system and built Patient Path NYC, a private patient advocacy service. She now spends 15 to 20 hours a week per client reading charts, coordinating care teams, and translating medical decisions into plain language. Her work sits in the uncomfortable space between healthcare policy and lived experience. Families pay out of pocket to understand their own care. Hospitals benefit from the clarity she provides while maintaining the same structural incentives that created the confusion.This conversation tracks the human cost of fragmented care, the economics behind discharge decisions, and the quiet reality that patients who cannot communicate clearly often lose control of their own outcomes.RELATED LINKSShlomit LibertyShlomit Liberty on LinkedInPatient Path NYCBoard Certified Patient AdvocateFEEDBACKLike this episode? Rate and review Out of Patients on your favorite podcast platform. For guest suggestions or sponsorship email podcasts@matthewzachary.comSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

It's In The News, where we bring you the top diabetes stories and headlines happening now. Top stories this week: Dexcom shares details of its next generation CGM, T1D and GLP-1 studies, weight loss management on GLP-1 medications updates, all-in-one CGM and pump, and more! Announcing Community Commericals! Learn how to get your message on the show here. Learn more about studies and research at Thrivable here Please visit our Sponsors & Partners - they help make the show possible! Omnipod - Simplify Life All about Dexcom  All about VIVI Cap to protect your insulin from extreme temperatures The best way to keep up with Stacey and the show is by signing up for our weekly newsletter: Sign up for our newsletter here Here's where to find us: Facebook (Group) Facebook (Page) Instagram Check out Stacey's books! Learn more about everything at our home page www.diabetes-connections.com  Episode transcript: XX Dexcom announces some features of it's next generation CGM – the G8. We've been talking about this with CEO Jake Leach for a while now – it will be a 50% smaller with what they're calling advanced sensing capabilities. According to Leach, G8 will adapt to the physiologic variability of each user. It has additional technology built in, based on a new silicon chip design and algorithm. 15 day wear is now the baseline for all Dexcom sensors moving forward. At launch the G8 will only measure glucose but the plan is for a multi-analyte version to follow. That would measure ketones and potassium. Ketones we know – but potassium is very important for people with kidney and possible for people taking some diabetes meds. It's an interesting space to watch.. btw, analyte is just a medical word for the specific thing you're measuring – the target of the test you're running. we're going to hear that word a lot I think..   Looks like an FDA submission for the G8 next year.. with an outside the US launch the following year. https://www.drugdeliverybusiness.com/dexcom-unveils-next-gen-g8-cgm/ XX Glucotrack has submitted its implantable continuous blood glucose monitor (CBGM) for FDA IDE, that's investigational device exemption and would enable the company to initiate a U.S. clinical study for the fully implantable technology. Rutherford, New Jersey-based Glucotrack's device features no on-body external component. The company aims to offer it for three years of continuous, accurate blood glucose monitoring for a more convenient, less intrusive solution. Unlike traditional CGMs that measure glucose in interstitial fluid, the CBGM measures glucose levels directly from the blood. The implant goes five centimeters within the subclavian vein. Glucotrack's active implantable device has a small battery and some electronics that go just under the skin in the pectoral region. The location of the implant is not in a major vessel, but the implant can measure real-time glucose levels as pulsatile blood flows over the tip of the sensor. https://www.drugdeliverybusiness.com/glucotrack-submits-long-term-implantable-cbgm-fda-ide/ XX PharmaSens today announced the publication of data from the first clinical study evaluating its all-in-one insulin patch pump offering. The all-in-one pump pairs the Niaa Essential insulin patch pump with the SynerG continuous glucose monitor (CGM) sensor developed by Pacific Diabetes Technologies. However, this system would be one device that features both the pump and CGM technology.   PharmaSens and SiBionics also have a collaboration aimed at developing the all-in-one solution. They are jointly developing the next-generation Niia insulin patch pump with a SiBionics CGM. PharmaSens expects a second feasibility study in the second quarter to evaluate the next-generation pump with SiBionics' CGM.   PharmaSens says the clinical feasibility study of Niia demonstrated for the first time ever that the combined offering is, in fact, feasible. It believes its device addresses the need for alternatives to multi-device diabetes management. systems.   Aggregated MARD for the investigational device came in at 11.6%. A MARD target of less than 10% is considered ideal for CGM devices, but PharmaSens said that, in the context of the early feasibility study, the results were encouraging and provide evidence supporting the development of an all-in-one system. https://www.drugdeliverybusiness.com/pharmasens-efs-insulin-patch-pump-cgm/ XX   XX ViCentra launches the newest version of the Kaleido pump system in Europe. This is that small colorful pump, with Diabeloops algorithm and the Dexcom G7. It'll be in Germany and the Netherlands later this summer. https://hellokaleido.com/vicentra-announces-commercial-launch-of-new-smartphone-controlled-kaleido-automated-insulin-delivery-patch-pump-system/--   XX Diabeloop just got CE Mark approval for DBLG2 integrations – it's latest AID platform the company has kicked off the gradual European launch of the technology. It currently offers DBLG2 as a smartphone application on Android, with iOS integration coming soon. As you just heard, it's integrated with kaleido and the company says it plans to make additional configuration for DBLG2 with alternative pumps "available soon." Running on a user's smartphone, DBLG2 works as a self-learning algorithm. It continuously analyzes glucose data, calculates insulin needs in real time and automatically adjusts delivery. https://www.drugdeliverybusiness.com/diabeloop-fda-next-gen-algorithm-g7/   XX Among adults with type 1 diabetes (T1D), the initiation of GLP-1-based therapy was associated with a lower risk for all-cause death, several cardiovascular outcomes, all-cause hospitalisations, and hypoglycaemia, without a higher risk for diabetic ketoacidosis.   METHODOLOGY: Researchers in Greece conducted a retrospective cohort study utilising real-world data from a global health research network to evaluate the association between GLP-1-based therapy and cardiovascular and renal outcomes in adults with T1D. A total of 4088 patients receiving GLP-1-based therapies (median age, 43 years; 34.3% men) were propensity score matched with an equal number of patients not receiving the treatment. The risk for hypoglycaemia was lower with GLP-1-based therapy (hazard ratio, 0.72; P = .021); however, the risk for diabetic ketoacidosis did not differ significantly between the two groups. https://www.medscape.com/viewarticle/glp-1-drugs-tied-cardiovascular-benefits-t1d-2026a1000fbx   XX Eli Lilly and Company (NYSE: LLY) today announced detailed results from two late-phase trials showing that people with obesity maintained their weight loss long term with either Foundayo or lower-dose Zepbound after switching from higher doses of injectable incretin therapy. The findings from SURMOUNT-MAINTAIN and ATTAIN-MAINTAIN, were presented at the 33rd European Congress on Obesity (ECO) and published in The Lancet and Nature Medicine, respectively.   "Weight regain remains one of the biggest challenges in obesity care, and is often the result of treatment interruptions that cause biology to work against patients, undoing the progress they've made," said Louis J. Aronne, M.D., FACP, DABOM, founder and Chair Emeritus of the American Board of Obesity Medicine, former president of The Obesity Society, Fellow of the American College of Physicians, world-renowned obesity specialist and Lilly consultant. "These medicines can be used for long-term maintenance today, and results from SURMOUNT-MAINTAIN and ATTAIN-MAINTAIN provide additional evidence of their potential when switching from higher doses of injectable incretin therapy." https://investor.lilly.com/news-releases/news-release-details/lillys-foundayo-and-lower-dose-zepbound-helped-people-maintain XX Scientists in Sweden have developed a more reliable way to create insulin-producing cells from human stem cells. These lab-grown cells not only respond strongly to glucose but were also able to restore blood sugar control when transplanted into diabetic mice. When transplanted into diabetic mice, the cells gradually restored the animals' ability to regulate blood sugar. Long way to go, as we say with most of these mice studies. https://www.sciencedaily.com/releases/2026/05/260505234620.htm XX Interesting look at how the body controls sugar storage – apparently this finding challenges long-standing biology concepts and could open new directions for disease treatment. Published in Nature, the study describes a potential method for directly reducing glycogen, the stored form of sugar in the body. These scientists discovered that glycogen can be directly regulated by ubiquitin, a protein best known for marking damaged proteins for recycling or removal. The study is the first to show that ubiquitin can regulate glycogen in humans, overturning more than 50 years of scientific understanding. Excess glycogen is also associated with more common health problems, including diabetes, obesity, liver disease, and heart disease.       https://scitechdaily.com/scientists-just-rewrote-biology-hidden-mechanism-could-transform-diabetes-treatment/ XX A new Oklahoma law will give parents the option to have their children screened for Type 1 Diabetes.   The measure passed with overwhelming bipartisan support in the Legislature and takes effect Nov 1. Oklahoma consistently ranks among the states with the highest rates of diabetes and diabetes-related deaths. The law gives parents access to antibody testing that can detect risk years before symptoms develop, helping families take preventive action and avoid emergency room visits. https://journalrecord.com/2026/05/11/oklahoma-law-expands-access-type-1-diabetes-screening/ XX More to come including a new study trying to figure out why some people are more likely to develop diabetes, a look at cannabis and preventing metabolic disorders, and XX   A National Institutes of Health (NIH)-funded study has identified key differences in human pancreatic islet cells that may help explain why some people are more likely to develop diabetes. Researchers found that the mix of hormone-producing cells in the pancreas varies widely from person to person, and that variation plays a central role in how the body regulates blood sugar. The study involved a deep dive into islet cell function that is linked to donor traits associated with observable characteristics, or phenotype, such as sex, race and ethnicity, as well as genetic information, or genotype, including predicted ancestry and genetic risk for both type 1 and type 2 diabetes. The findings highlight that islet cell composition, rather than the physical size and shape of islets, is a key factor in regulating hormone release. The team found that the makeup of pancreatic islets plays a major role in how effectively they release insulin and glucagon — key hormones that regulate blood glucose. Islets with a higher proportion of insulin-producing beta cells showed stronger insulin secretion in response to various stimuli, while higher levels of alpha and delta cells were generally linked to reduced insulin output. In addition, the researchers found that islet hormone secretion is affected by donor traits, such as sex, race and ethnicity and their genetic makeup, including ancestry predicted from genetic testing and genetic risk for type 2 diabetes. Combined, the findings of the study have significant implications for understanding the factors that may predispose people to diabetes. "This study is the tip of the iceberg," said Dr. Evans-Molina. "We hope this dataset becomes useful to the entire diabetes research community and that researchers use it to answer questions about the genotype-phenotype correlation within these data."   https://www.nih.gov/news-events/news-releases/nih-funded-study-maps-human-pancreatic-islet-cells-offering-new-clues-diabetes-risk XX XX XX Research published recently in JAMA Network Open offers illuminating evidence suggesting there is a positive association between GLP-1 agonists—drugs commonly used to treat obesity and diabetes—and better outcomes among breast cancer patients.   "This study suggests that GLP-1 drugs may offer protective benefits potentially improving survival and recurrence risk in some female patients with breast cancer – whether this is related to weight control, improve cardiovascular health or other mechanisms remains to be studied," said study senior author Bernard F. Fuemmeler, Ph.D., MPH, associate director for population sciences and the Gordon D. Ginder, M.D., Chair in Cancer Research at VCU Massey Comprehensive Cancer Center.   Breast cancer patients who are also obese or have type 2 diabetes experience more aggressive cancer growth and worse outcomes. Prior studies have shown that weight loss treatment and surgery following a breast cancer diagnosis are associated with improved heart health and increased survival.   What are GLP-1 drugs? Glucagon-like peptide-1 receptor agonists (GLP-1 RAs). Approved to treat type 2 diabetes in 2005 and weight management in 2021. Impacts on breast cancer survival and recurrence are still unclear. Since 2020, the use of these drugs has increased dramatically, where approximately 12% of Americans have used GLP-1s for weight loss, according to a RAND report.   The research findings Through a retrospective cohort study examining the electronic health records of more than 840,000 breast cancer patients who were diagnosed between 2006 and 2023, the results suggest there is a potential link between GLP-1 RAs and improved outcomes among breast cancer patients who are also obese or have type 2 diabetes.   GLP-1 RA use was associated with an overall lower risk of death from any cause over a 10-year follow-up period among breast cancer patients. Additionally, breast cancer survivors who used GLP1-RAs for diabetes or obesity had a significantly lower risk of their cancer returning over 10 years following their initial treatment.   "Our findings align with emerging preclinical research and contribute to a growing body of literature related to GLP-1 RA use in oncology settings," said study lead author Kristina L. Tatum, PsyD, MS, of the VCU School of Public Health.   What's next? Further studies are needed to understand the biological mechanisms, if any, between GLP-1 RAs and breast cancer outcomes. The research team intends to further evaluate these correlations through randomized clinical trials.   "Our study underscores the potential of GLP-1 RAs as an adjunct strategy for improving cancer-related outcomes among patients with breast cancer, although clinical trials are needed to inform effective therapeutic approaches and clinical decision making," Fuemmeler said. https://www.oncology-central.com/could-glp-1-receptor-agonists-improve-outcomes-for-breast-cancer-patients-with-obesity-or-with-type-2-diabetes/ XX Researchers at UC Riverside gave cannabis to obese mice and found that not only did the rodents lose weight, but when given a concentrated cannabis oil, the mice also saw striking benefits in their metabolic function. DiPatrizio said his team studied the issue to better understand why cannabis users show significant reductions in weight and risk for diabetes compared with nonusers. "We would think that chronic cannabis users would be eating more and weigh more, but it's just the opposite," DiPatrizio said. Scientists are increasingly examining the possibility that cannabis compounds could fight obesity or metabolic disorders like diabetes. Cannabinoids interact with the body's endocannabinoid system, which partially controls nearly every aspect of our physiology, including metabolism and appetite. That creates the possibility that targeting this widespread system could unlock new therapies for these conditions. https://www.sfgate.com/cannabis/article/cannabis-weight-loss-california-study-22255328.php XX A new campaign launched by diaTribe and Genentech aims to empower and educate people about diabetes-related eye disease. Here's what you can do today to protect your eye health. To help address these barriers, diaTribe and Genentech partnered to launch All Eyes on DME, a new campaign that aims to spread awareness and educate people at-risk for or living with diabetes-related eye conditions like DME. Also partnering in the campaign is actor and comedian Damon Wayans, who wanted to share his journey (and, of course, a joke or two) with type 2 diabetes to open up the conversation about what is often a stigmatized or less talked about topic: eye health and diabetes.   One of these important conversations happened recently at the All Eyes on DME launch in New York City, where Wayans joined a panel of experts, advocates, and people living with DME to talk about diabetes-related eye disease and how to help prevent it. https://www.alleyesondme.com/dme-in-the-spotlight.html https://diatribe.org/diabetes-complications/all-eyes-dme-new-campaign-spotlights-eye-health-and-diabetes

In this episode, Kim Louise, Medical Intuitive & Holistic Nutritionist, speaks with John Lavack - a gifted energy healer who has worked with clients in over 46 countries for over 30 years. John blends Rapid Image Cycling (a modality developed by the late, great Dr. William Bengston) with a wide range of healing modalities including psychosomatics, neuro-linguistic programming (NLP), bioenergy balancing, intuitive development, and hands-on energy practices. Together we explore how John integrates these tools to help clients shift belief structures, release patterns, and transform health and personal life outcomes all while grounding his work in research settings including the Institute of Noetic Sciences, Beech Tree Labs, and MD Anderson Cancer Center. What you'll discover: • Amazing Stories from decades of helping to heal clients worldwide • How John combines multiple modalities for deeper healing impact • Why shifting belief frameworks matters in energy work • Practical tools like charged cotton & water for energy healing  • How science and energy healing are beginning to intersect • How you can learn Rapid Image Cycling for yourself and to heal others with it - including animals If you're curious about multi-modal energy healing, this conversation offers insight, inspiration, and practical takeaways.  Guest: John Lavack, Energy Healer and Facilitator Contact: (650) 743-4559 Host: Kim Louise, Medical Intuitive and Holistic Nutritionist To schedule a free 15-minute call with me to see if I'm the right fit for your needs, go to: www.kimlouisemedicalintuitive.com Dr. William Bengston's website regarding his research and Rapid Image Cycling classes: https://bengstonresearch.com/ Video with Dr. William Bengston on New Thinking Allowed: https://youtu.be/V-YPt6L45p0?si=RSOen83S8KqtVZhl Dr. William Bengston's video about mummifying bananas: https://youtu.be/0Ca4e3cSi3g?si=dKdV3_YyWupS1PkY Disclaimer: This content is for educational purposes only. It does not diagnose, treat, or cure. Please consult a licensed healthcare provider for medical concerns.

Partner with Jay! https://www.jayschwedelson.com/contactㅤPre-order Jay Schwedelson's new book, Stupider People Have Done It (out June 9, 2026). All net proceeds are donated to The V Foundation for Cancer Research—let's kick cancer's butt: https://www.amazon.com/Stupider-People-Have-Done-Marketing/dp/1637635206ㅤCheck out Jay's YOUTUBE Channel: https://www.youtube.com/@schwedelsonCheck out Jay's TIKTOK: https://www.tiktok.com/@schwedelsonCheck Out Jay's INSTAGRAM: https://www.instagram.com/jayschwedelson/ㅤFollow Daniel on LinkedIn and check out The Marketing Millennials podcast for sharp, no-fluff marketing insights. Subscribe to Ari Murray's newsletter at gotomillions.co for sharp, actionable marketing insights.ㅤJune is about to get weird for marketers, and most people aren't ready for it. Jay Schwedelson and Daniel Murray get into why the back half of the month quietly tanks webinar attendance, how the World Cup landing on US soil reshapes the email game, and why Amazon shifting Prime Day to early June matters even if you sell B2B software. A heated detour into cloth diapers also happens, because of course it does.ㅤBest Moments:(03:00) The three week dead zone that quietly tanks webinar show-ups and B2B content downloads(03:50) Why the FIFA World Cup landing across US host cities changes your email strategy(04:37) The themed subject line angle that plays into game day energy(06:10) Amazon moving Prime Day to the second week of June and what it means for every marketer(06:45) Why inbox time jumps 15 percent during Prime Day, even for B2B audiences(06:59) The Shopify lift nobody talks about during Prime Day week

One Creatine Dose Kept Sleep-Deprived Brains 12% Sharper A randomized, double-blind crossover trial kept 29 healthy adults awake for 21 hours straight ... half the time on a single moderate dose of creatine (~14g), half the time on placebo ... and found the creatine group held on to up to 12% more cognitive performance across logic, reaction time, and language processing. Host Dave Asprey breaks down why sleep deprivation is just another form of brain energy stress, how creatine's phosphate-buffering mechanism stabilizes ATP in the prefrontal cortex under pressure, and why this changes how he thinks about red-eye flights and all-nighters. Vegetarians and women showed the largest effects ... your baseline diet sets your ceiling. Sources: https://pubmed.ncbi.nlm.nih.gov/42075005/ https://www.nutraingredients.com/Article/2026/04/21/single-dose-creatine-may-support-cognition-in-sleep-deprivation-study/ https://pmc.ncbi.nlm.nih.gov/articles/PMC10902318/ https://medicalxpress.com/news/2024-04-creatine-cognitive-deprivation.html Your Gum Is Dosing You With Thousands of Microplastics A pilot study tested 10 commercial gums ... five synthetic, five marketed as natural or plastic-free ... and found every single one shed hundreds to roughly 3,000 microplastic fragments per stick into saliva, with no meaningful difference between synthetic and "natural" varieties. Host Dave Asprey connects this to total toxic load management, explains why "natural" label claims mean nothing without polymer-free verification, and makes the case that even innocent daily habits contribute to the cumulative plastic burden most people aren't tracking. The takeaway isn't panic ... it's precision. Sources: https://www.acs.org/pressroom/presspacs/2025/march/chewing-gum-can-shed-microplastics-into-saliva-pilot-study-finds.html https://www.sciencedirect.com/science/article/pii/S2666911025000243 https://samueli.ucla.edu/bursting-your-bubble-chewing-gum-releases-microplastics-into-your-saliva-ucla-research-shows/ https://www.food-safety.com/articles/10285-study-shows-chewing-gum-releases-thousands-of-microplastics-whether-gum-is-synthetic-or-natural Irregular Bedtimes in Your 40s May Double Heart Attack Risk Finnish researchers followed 3,231 people from age 46 using objective accelerometer data and tracked cardiovascular outcomes for a decade ... finding that people with highly irregular bedtimes, especially combined with short sleep, had roughly double the risk of major cardiovascular events compared to those with consistent sleep timing. Host Dave Asprey explains why your vascular biology runs on a precise circadian schedule, why ambitious, otherwise-healthy people are most at risk of ignoring this lever, and why a 90-minute bedtime window ... protected even on weekends ... may be one of the cheapest cardiovascular interventions available. It'snot just how much you sleep. It's when. Sources: https://www.sciencedaily.com/releases/2026/05/260504154026.htm https://hsph.harvard.edu/topic/aging/ Scientists Decode the Plant Molecule That Kills Cancer Cells in the Lab UBC researchers published a chromosome-level genome map of Mitragyna parvifolia ... a kratom relative ... and used it to decode the full biosynthetic pathway for mitraphylline, a rare alkaloid that has shown real anti-tumor activity in cell and animal models but has never been producible at clinical scale. Host Dave Asprey explains why this is the same early chapter that vincristine and paclitaxel were in before becoming mainstream chemotherapy, draws a hard line between this pipeline story and influencer narratives about kratom as a cancer treatment, and breaks down what it actually means when researchers crack a plant's genetic recipe for a bioactive compound. Nature has been solving cancer for millions of years... we're finally learning to read it. Sources: https://academic.oup.com/plcell/article/37/9/koaf207/8237526 https://www.sciencedaily.com/releases/2026/05/260512213836.htm https://news.ok.ubc.ca/2025/10/14/researchers-reveal-how-plants-make-anti-tumour-drugs/ https://pmc.ncbi.nlm.nih.gov/articles/PMC12217235/ Scientists Built an On/Off Switch for Sperm Production — No Hormones Cornell researchers used a small-molecule inhibitor called JQ1 to pharmacologically shut down sperm production in male mice for the duration of treatment, then stopped the drug and watched full fertility restore... with healthy offspring and no detectable genomic damage. Host Dave Asprey breaks down the BRDT mechanism that makes this work without touching testosterone or hormones, explains why this is a proof-of-concept rather than a near-market drug, and outlines the questions that need answering before this moves to humans: long-term testicular health, epigenetic marks in recovered sperm, and mood and testosterone interaction over time. The era of precision male reproductive biology is just beginning. Sources: https://pubmed.ncbi.nlm.nih.gov/41945432/ https://www.sciencedaily.com/releases/2026/04/260407193844.htm https://www.news-medical.net/news/20260407/Study-advances-safe-reversible-male-contraceptive-without-hormones.aspx https://www.independent.co.uk/news/science/breakthrough-male-birth-control-sperm-b2972841.html This episode is designed for biohackers, longevity seekers, and high-performance listeners who want mechanism-level clarity on cognitive performance, toxic load management, circadian biology, plant-derived drug discovery, and the future of male reproductive medicine. Host Dave Asprey connects emerging clinical research, objective epidemiological data, and real-world optimization protocols into actionable frameworks for extending healthspan, sharpening performance, and staying ahead of the science. New episodes every Tuesday, Thursday, Friday, and Sunday. Keywords: creatine sleep deprivation cognition, brain energy ATP creatine, microplastics chewing gum, natural gum microplastics, toxic load biohacking, irregular bedtime heart attack risk, circadian rhythm cardiovascular, sleep timing heart health, mitraphylline cancer compound, kratom plant alkaloid drug discovery, oncolytic plant molecule, male birth control non-hormonal, sperm production reversible, BRDT JQ1 contraception, biohacking news 2026, longevity research, performance optimization, healthspanextension Thank you to our sponsors! - KILLSwitch | If you're ready for the best sleep of your life, order now at https://www.switchsupplements.com/and use code DAVE for 20% off - ALP | Head to http://alppouch.com/ and use code DAVE for 20% off your first order - iRestore | Reverse hair loss at www.irestore.com/DAVE and get exclusive savings on the iRestore Elite, use code DAVE Resources: • Get My 2026 Clean Nicotine Roadmap | Enroll for free at https://daveasprey.com/2026-clean-nicotine-roadmap/ • Get My 2026 Biohacking Trends Report: https://daveasprey.com/2026-biohacking-trends-report/ • Dave Asprey's Latest News | Go to https://daveasprey.com/ to join Inside Track today. • Danger Coffee: https://dangercoffee.com/discount/dave15 • My Daily Supplements: SuppGrade Labs (15% Off) • Favorite Blue Light Blocking Glasses: TrueDark (15% Off) • Dave Asprey's BEYOND Conference: https://beyondconference.com • Dave Asprey's New Book – Heavily Meditated: https://daveasprey.com/heavily-meditated • Join My Substack (Live Access To Podcast Recordings): https://substack.daveasprey.com/ • Upgrade Labs: https://upgradelabs.com Timestamps: 00:00 – Intro 00:36 – Fluoride Correction 01:14 – Story 1: Creatine & Sleep Deprivation 03:21 – Story 2: Microplastics in Gum 04:53 – Story 3: Irregular Bedtimes & Heart Risk 06:31 – Story 4: Kratom Plant & Cancer Research 08:18 – Story 5: Male Contraception On/Off Switch 10:02 – Wrap-Up See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Partner with Jay! https://www.jayschwedelson.com/contactㅤPre-order Jay Schwedelson's new book, Stupider People Have Done It (out June 9, 2026). All net proceeds are donated to The V Foundation for Cancer Research—let's kick cancer's butt: https://www.amazon.com/Stupider-People-Have-Done-Marketing/dp/1637635206ㅤCheck out Jay's YOUTUBE Channel: https://www.youtube.com/@schwedelsonCheck out Jay's TIKTOK: https://www.tiktok.com/@schwedelsonCheck Out Jay's INSTAGRAM: https://www.instagram.com/jayschwedelson/ㅤMASSIVE thank you to our Sponsor, CallRail!CallRail is the AI-powered lead intelligence platform that helps marketers prove exactly what's driving results. With CallRail, you can connect every call, text, chat, and form submission directly to the campaign that generated it so you finally know what's working and where to double down.Plus, with built-in AI conversation intelligence, CallRail analyzes your customer conversations, captures leads 24/7, and gives you deeper insights into what your prospects actually care about.If you're tired of guessing about your marketing ROI and want real data behind your campaigns, CallRail has you covered.Start a Free Trial Here: https://www.callrail.com/dothisㅤEver notice how one tiny word can decide whether someone clicks or scrolls right past you? That's the rabbit hole Jay Schwedelson climbs into this week, making the case that "without" might be the most underrated word in marketing and that your audience is far more beginner than your ego wants to admit. Stick around for the second half, where a listener's block-party dilemma turns into a surprisingly honest confession about 16 years of dodging the people next door.ㅤBest Moments:(01:30) How the no-code movement quietly trained everyone to expect easy(02:17) A plain-English definition of cognitive load and why it drives every yes or no(02:45) The one word that lifts opens, engagement, and conversions across every audience(03:43) Side-by-side offer rewrites that make "without" click instantly(05:01) Why marketers overestimate their audience and ignore the beginners who actually convert(06:57) A dog, a stare, and Jay's real answer on block-party guilt

An upcoming resupply mission will carry tumor samples to the International Space Station for research. Experiments in microgravity have yielded shocking results: Some tumors triple in size in just 10 days—the kind of growth that could take 10 years on Earth. What does that mean for science, and for astronauts?  Joining Ira to discuss this new frontier in cancer research are hematologist Catriona Jamieson and aerospace engineer Meenal Datta. Guests:  Dr. Catriona Jamieson is a hematologist at the UC San Diego Health Moores Cancer Center in California. Dr. Meenal Datta studies the physics of cancer at the University of Notre Dame's College of Engineering in Indiana. Other episodes you may enjoy: How A Fringe Idea Led To Lifesaving Cancer Treatments To Get Ready For Mars, NASA Studies How The Body Changes In Space Want SciFri gear? Check out our new shop! Transcripts for each episode are available within 1-3 days at sciencefriday.com. Subscribe to this podcast. Follow our show on Instagram, TikTok, Facebook, and Bluesky @scifri and sign up for our newsletters. Got a science question that's keeping you up at night? Call us: 877-4-SCIFRI Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Partner with Jay! https://www.jayschwedelson.com/contactㅤPre-order Jay Schwedelson's new book, Stupider People Have Done It (out June 9, 2026). All net proceeds are donated to The V Foundation for Cancer Research—let's kick cancer's butt: https://www.amazon.com/Stupider-People-Have-Done-Marketing/dp/1637635206ㅤCheck out Jay's YOUTUBE Channel: https://www.youtube.com/@schwedelsonCheck out Jay's TIKTOK: https://www.tiktok.com/@schwedelsonCheck Out Jay's INSTAGRAM: https://www.instagram.com/jayschwedelson/ㅤMASSIVE thank you to our Sponsor, CallRail!CallRail is the AI-powered lead intelligence platform that helps marketers prove exactly what's driving results. With CallRail, you can connect every call, text, chat, and form submission directly to the campaign that generated it so you finally know what's working and where to double down.Plus, with built-in AI conversation intelligence, CallRail analyzes your customer conversations, captures leads 24/7, and gives you deeper insights into what your prospects actually care about.If you're tired of guessing about your marketing ROI and want real data behind your campaigns, CallRail has you covered.Start a Free Trial Here: https://www.callrail.com/dothisㅤIf your attribution model is telling you to dump everything into branded paid search, congratulations, you've just found a fast way to flatline your pipeline. Laura Beussman, CMO and CRO at CallRail, sat down with Jay Schwedelson to push back on the idea that attribution is dead, and to make the case that the real problem isn't measurement, it's marketers oversimplifying it. Spoiler: she has the patent and the 20 million call dataset to back it up.ㅤConnect with Laura Beussman on LinkedIn and try CallRail free at callrail.com/dothis to see how attribution, call tracking, and conversational AI actually fit together for your business.ㅤBest Moments:(01:43) Why "attribution is dead" is mostly clickbait dressed up as a hot take(03:17) The trap of trusting a beautiful chart that tells you to spend on one channel(04:29) Self-reported attribution and why CallRail holds the patent on it(06:26) Conversational AI now picks up call sentiment, next steps, and coaching moments(08:00) What it actually feels like owning marketing and revenue under one job title(13:29) LLM traffic is still tiny but growing fast, and the discovery game has changed(15:21) The hide-in-your-room versus go-to-the-dinner debate at industry events

In 2020, developmental biologist Dr. Crystal Rogers drove the country roads outside Davis, California crying between grant rejections, wondering whether she was about to lose her lab, her career, and the scientific future she had spent years building. She had already done what academia tells young scientists to do. She earned the credentials. She landed a faculty position at UC Davis. She built a lab. Then the real test began.On this episode of Standard Deviation, Dr. Oliver Bogler examines the unspoken rules that determine which scientists survive academic research and which quietly disappear from it. The conversation follows Crystal Rogers and cancer biologist Dr. Michelle Mendoza as they collide with the “Hidden Curriculum” of biomedical science: the unwritten rhetoric, institutional signaling, and grant writing strategies that often decide who receives funding, tenure, and long term stability.Michelle Mendoza entered a tenure track position at the Huntsman Cancer Institute while raising 3 children, navigating a divorce, and trying to secure major NIH funding during COVID. What looked like objective scientific review turned out to depend heavily on persuasion, presentation, and insider fluency. Established researchers could promise massive research agendas based on reputation alone. Junior investigators faced a completely different standard.Oliver traces how the Life Science Editors Foundation and its JEDI program intervened by pairing scientists with former editors from journals including Cell and Nature. The work had little to do with commas or grammar. Editors challenged logic, structure, and scientific framing before grant reviewers could destroy an application in public.Both researchers eventually secured career defining grants. One realized she would keep her job and not have to move her family. The other celebrated by ordering a personalized “DEV BIO” license plate and driving through Davis blasting nineties hip hop and Beyoncé.The episode exposes how biomedical research funding rewards institutional fluency as much as scientific talent, and how hidden systems inside academic medicine continue shaping who gets to stay in science long enough to make discoveries.RELATED LINKSDr. Crystal Rogers LinkedInDr. Crystal Rogers Faculty PageDr. Crystal Rogers LabDr. Michelle Mendoza LinkedInDr. Michelle Mendoza Faculty PageHuntsman Cancer Institute Mendoza LabLife Science Editors FoundationFEEDBACKLike this episode? Rate and review Out of Patients on your favorite podcast platform. For guest suggestions or sponsorship email podcasts@matthewzachary.comSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Partner with Jay! https://www.jayschwedelson.com/contactㅤPre-order Jay Schwedelson's new book, Stupider People Have Done It (out June 9, 2026). All net proceeds are donated to The V Foundation for Cancer Research—let's kick cancer's butt: https://www.amazon.com/Stupider-People-Have-Done-Marketing/dp/1637635206ㅤCheck out Jay's YOUTUBE Channel: https://www.youtube.com/@schwedelsonCheck out Jay's TIKTOK: https://www.tiktok.com/@schwedelsonCheck Out Jay's INSTAGRAM: https://www.instagram.com/jayschwedelson/ㅤHalf the planet opens a Meta app every single day, but The New York Times just ran a piece arguing it's the beginning of the end. Jay Schwedelson is not buying that one, and he's got fresh data on the fourteen-day window that quietly decides whether a new subscriber ever opens another email from you again. That, plus what an obvious AI fail from the Indiana Fever says about the rush to use AI for everything.ㅤBest Moments:(00:43) The OpenAI ad manager just killed its minimum spend, and early cost per click is landing at three to five dollars(01:40) Why The New York Times's calling Meta dead doesn't hold up when half the planet uses one of its apps daily(03:09) The brutal fourteen-day window where engagement likelihood drops sixty-one percent if a new subscriber never opens or clicks(04:49) The Indiana Fever turned Caitlin Clark into an AI image, and the hands gave the whole thing away(05:30) Delta is pulling free snacks on flights under 350 miles, and the hot take might surprise you(06:56) Apple agreed to pay 250 million over false advertising claims tied to Siri and Apple Intelligence

In 2008, Katy Talento walked away from Capitol Hill and into a Catholic convent. Within a year, she walked out. Within another decade, she sat inside the White House shaping health policy. Somewhere in between, she got labeled “infertile” after a single cycle of testing and spent years believing it.That label stuck. The pain that came before it never got investigated. Doctors offered birth control and moved on. No one asked why her body was struggling. No one followed the thread.Talento built her career inside the very systems she now critiques. She worked on federal health policy, global disease programs, and later advised the Trump administration on healthcare reform. She helped advance price transparency rules in a system where hospitals can still list 457 different prices for the same service.Then she left.Now she builds employer health plans that bypass insurers, PBMs, and traditional networks. Her approach replaces insurance contracts with direct payment, nurse navigators, and cost sharing models that promise simplicity but raise hard questions about risk and protection.This conversation sits in that tension.Talento describes a healthcare system shaped by layered incentives, where insurers, hospitals, and intermediaries profit from complexity. She argues that employers hold the leverage to disrupt it. The host pushes on what happens when patients fall outside those structures, when contracts disappear, and when community based models fail.The episode moves through infertility, misdiagnosis, insurance design, and the mechanics of employer sponsored care. It tracks how policy decisions made in Washington ripple into exam rooms, billing departments, and family lives.It also confronts a harder truth.Even insiders who understand the system can still get caught in it.RELATED LINKSAllBetter HealthKaty TalentoThem Before UsAn Arm and a LegRelentless Health ValueFEEDBACKLike this episode? Rate and review Out of Patients on your favorite podcast platform. For guest suggestions or sponsorship email podcasts@matthewzachary.comSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Partner with Jay! https://www.jayschwedelson.com/contactㅤPre-order Jay Schwedelson's new book, Stupider People Have Done It (out June 9, 2026). All net proceeds are donated to The V Foundation for Cancer Research—let's kick cancer's butt: https://www.amazon.com/Stupider-People-Have-Done-Marketing/dp/1637635206ㅤCheck out Jay's YOUTUBE Channel: https://www.youtube.com/@schwedelsonCheck out Jay's TIKTOK: https://www.tiktok.com/@schwedelsonCheck Out Jay's INSTAGRAM: https://www.instagram.com/jayschwedelson/ㅤSome of the LinkedIn tactics that actually move the needle right now feel a little ridiculous to admit out loud, and Jay Schwedelson and Daniel Murray get into the ones they're using anyway. There's a very specific image size, a self-saving trick, and a hard warning about the kind of automation that will quietly nuke your account. Plus a tangent about toddler swim lessons and a pet elephant named Hakuna Matata, because of course.ㅤFollow Daniel on LinkedIn and check out The Marketing Millennials podcast for sharp, no-fluff marketing insights. Subscribe to Ari Murray's newsletter at gotomillions.co for sharp, actionable marketing insights.ㅤBest Moments:(00:45) Why being a new dad means swim lessons four mornings a week with weirdly strict food rules(03:17) The 800 by 999 image size that takes over the entire LinkedIn feed(04:30) The cheesy save-and-send trick Jay does ten minutes after every post goes live(05:16) Why liking your own post is actually a reach hack, not a sin(06:25) The LinkedIn automation tool that quietly killed Jay's engagement overnight(07:18) What LinkedIn actually allows versus what gets your account banned for weeks(08:07) Why ManyChat-style DM automation works on Instagram but never on LinkedIn

Partner with Jay! https://www.jayschwedelson.com/contactㅤPre-order Jay Schwedelson's new book, Stupider People Have Done It (out June 9, 2026). All net proceeds are donated to The V Foundation for Cancer Research—let's kick cancer's butt: https://www.amazon.com/Stupider-People-Have-Done-Marketing/dp/1637635206ㅤCheck out Jay's YOUTUBE Channel: https://www.youtube.com/@schwedelsonCheck out Jay's TIKTOK: https://www.tiktok.com/@schwedelsonCheck Out Jay's INSTAGRAM: https://www.instagram.com/jayschwedelson/ㅤCranking out more content with AI, but watching engagement quietly tank? Jay Schwedelson breaks down why polished AI output is dragging performance down and shares the weirdly casual button copy, screenshot formats, and webinar title tweaks that are actually lifting clicks right now. Plus a round of ridiculous debates that may or may not include why saying "we need rain" is the most annoying sentence in the English language.ㅤBest Moments:(01:53) Why cranking out more AI content is quietly dragging engagement down(02:34) Screenshot testimonials lifting conversions 22% over standard case studies(03:29) The casual "maybe" CTA buttons pulling 14% higher click-throughs(04:13) The webinar title format crushing polished educational content right now(04:45) Why day in the life content wins even in regulated and boring industries(07:00) The public speakerphone offense that nobody on earth should ever commit

Partner with Jay! https://www.jayschwedelson.com/contactㅤPre-order Jay Schwedelson's new book, Stupider People Have Done It (out June 9, 2026). All net proceeds are donated to The V Foundation for Cancer Research—let's kick cancer's butt: https://www.amazon.com/Stupider-People-Have-Done-Marketing/dp/1637635206ㅤCheck out Jay's YOUTUBE Channel: https://www.youtube.com/@schwedelsonCheck out Jay's TIKTOK: https://www.tiktok.com/@schwedelsonCheck Out Jay's INSTAGRAM: https://www.instagram.com/jayschwedelson/ㅤCheck out Thorne (T-H-O-R-N-E) at thorne.com to explore their supplements and wellness tools, and connect with Mary Beech on social to follow her work leading growth.ㅤRunning the second half of a marathon faster than the first sounds borderline impossible, but Mary Beech treats that idea (the negative split) as a life philosophy. As Chief Growth Officer at Thorne, she sat down with Jay Schwedelson to get into why Gen Z will sit through an hour-long Reddit AMA but scroll right past your TikTok, why 65% of Americans say picking a supplement is more confusing than filing their taxes, and what actually changes when a marketer trades the CMO seat for full P&L ownership.ㅤBest Moments:(03:45) Why she'd never go backwards to CMO and what the CGO title really unlocks(05:30) Her head of sales is her closest peer at Thorne, on purpose(07:45) The wellness confidence stat that should make every marketer rethink their content(08:30) Gen Z's split brain, six-second ads and hour-long Reddit AMAs in the same week(13:30) Why TikTok hasn't cracked for a clinical supplement brand even though everyone else is winning there(18:45) The negative split applied to your career, today gets to be better than yesterday ㅤ

Partner with Jay! https://www.jayschwedelson.com/contactㅤPre-order Jay Schwedelson's new book, Stupider People Have Done It (out June 9, 2026). All net proceeds are donated to The V Foundation for Cancer Research—let's kick cancer's butt: https://www.amazon.com/Stupider-People-Have-Done-Marketing/dp/1637635206ㅤCheck out Jay's YOUTUBE Channel: https://www.youtube.com/@schwedelsonCheck out Jay's TIKTOK: https://www.tiktok.com/@schwedelsonCheck Out Jay's INSTAGRAM: https://www.instagram.com/jayschwedelson/ㅤBig shoutout to our sponsor, Knak!Marketers, you know the pain… You spend hours on a campaign, and then it gets stuck in review cycles and barely looks like what you started with.Knak makes it simple. Design emails and landing pages, collaborate, and launch - all in one place. No tool hopping, no messy handoffs, with AI built in to help you move faster.See how it all works, get started at knak.com/demoㅤTurns out Gmail and Apple Mail are quietly scanning your emails for very specific phrases, and if you're not using them, your open rates are leaking out the back door. Jay Schwedelson breaks down the new Attentive data on signal phrases, why Duolingo's plan to be "less unhinged" might be a strategic miscalculation, and a Google AI mode stat that should make every marketer obsess over their email list. There's also a Gravitron story from 1989 that you absolutely cannot unhear.ㅤBest Moments:(00:30) The new "signal phrases" AI email summaries are hunting for at the top of your messages(01:15) Why "What's included:" is the number one structural cue beating every other phrase(02:15) Duolingo's CMO promising fewer butt jokes and why that's the wrong call(03:30) Reddit's 69% ad growth and why intent beats scrolling brain rot every time(05:00) Google AI mode hits 75 million daily users with 93% zero-click queries(06:15) The Gravitron incident, the angry adult, and a $10 shirt purchase at age nine

In a wooded campground cabin in the early 2000s, 19 year old Ben Unger stood in the doorway and watched 20 naked men form a circle around a crying teenager. A counselor held up two tangerines and shouted, “These are your balls.” The exercise claimed to cure same sex attraction by forcing young men to “reclaim” their masculinity from overbearing mothers. Phones had been confiscated. Parents had paid thousands of dollars. Religion supplied the script. Pseudoscience supplied the props.Ben had grown up in an Orthodox Jewish community in Brooklyn and later studied in Israel to become a rabbi. When he admitted he felt attracted to men, rabbis told him to eat 7 figs a day, immerse in a ritual bath 5 times daily, or marry a woman and trust that “if there's friction, it works.” At 19, he entered conversion therapy through an organization called Jews Offering New Alternatives to Homosexuality, known as JONAH. He left with depression, religious trauma, and 6 months of silence toward the mother he had been taught to blame.Years later, represented by the Southern Poverty Law Center, Ben helped sue JONAH for consumer fraud in a landmark New Jersey case. The argument centered on evidence, not theology. Sexual orientation cannot be changed. The jury deliberated for 3 hours and ruled against the organization. The verdict helped reshape how states regulate conversion therapy and protect minors from psychological harm disguised as treatment.Today, Ben runs Buff Personal Training in New York City, a gym built on autonomy, mental health, and self respect. His story traces the arc from institutional control to self authorship. The conversation examines religion, LGBTQ rights, conversion therapy, consumer protection law, and the lasting cost of being told your identity is a disorder.RELATED LINKSBen Unger on LinkedInBen Unger on InstagramBUF Personal TrainingSouthern Poverty Law CenterJONAHFEEDBACKLike this episode? Rate and review Out of Patients on your favorite podcast platform. For guest suggestions or sponsorship email podcasts@matthewzachary.comSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Partner with Jay! https://www.jayschwedelson.com/contactㅤPre-order Jay Schwedelson's new book, Stupider People Have Done It (out June 9, 2026). All net proceeds are donated to The V Foundation for Cancer Research—let's kick cancer's butt: https://www.amazon.com/Stupider-People-Have-Done-Marketing/dp/1637635206ㅤCheck out Jay's YOUTUBE Channel: https://www.youtube.com/@schwedelsonCheck out Jay's TIKTOK: https://www.tiktok.com/@schwedelsonCheck Out Jay's INSTAGRAM: https://www.instagram.com/jayschwedelson/ㅤTwo platform updates dropped this week that quietly change the math for B2B marketers, and Jay Schwedelson and Daniel Murray get into both before the AC kicks in. LinkedIn finally killed the worst part of running event ads, Instagram just made it painfully obvious which videos people skip, and there's a tight window to ride the algorithm before the rest of the crowd catches on.ㅤFollow Daniel on LinkedIn and check out The Marketing Millennials podcast for sharp, no-fluff marketing insights. Subscribe to Ari Murray's newsletter at gotomillions.co for sharp, actionable marketing insights.ㅤBest Moments:(02:39) LinkedIn just killed the event page workaround that's been wasting marketers' time for years(03:31) Why off-platform event ads should bring webinar registration costs down fast(03:49) Instagram pushed share rate and skip rate front and center this week(04:31) The first two seconds are the headline of your video, and skip rate will rat you out(05:47) Platforms quietly amplify whoever jumps on their new features first(06:28) Get in early on the events feature before CPMs climb with the crowdㅤFollow the Marketing Millennials podcast and tune into the weekly Bathroom Break series. Connect with Daniel on LinkedIn to tell him what marketing topics you want covered next.ㅤ

Partner with Jay! https://www.jayschwedelson.com/contactㅤPre-order Jay Schwedelson's new book, Stupider People Have Done It (out June 9, 2026). All net proceeds are donated to The V Foundation for Cancer Research—let's kick cancer's butt: https://www.amazon.com/Stupider-People-Have-Done-Marketing/dp/1637635206ㅤCheck out Jay's YOUTUBE Channel: https://www.youtube.com/@schwedelsonCheck out Jay's TIKTOK: https://www.tiktok.com/@schwedelsonCheck Out Jay's INSTAGRAM: https://www.instagram.com/jayschwedelson/ㅤFive hundred episodes in, and the celebration is reading hate mail. Jay Schwedelson cracks open a year's worth of nasty unsubscribes, brutal reviews, and one dagger that reads "no one would miss this if you stopped." Somewhere between the salmon complaints and the "man card" insult, there's an actual point about why turning some people off is the cost of being worth listening to.ㅤBest Moments:(00:38) Why the early hour-long interviews almost killed the show before it started(02:04) The exact reply that goes back to every mean unsubscribe(03:03) Pushing back on the AI environmental damage hate mail(04:45) The weekly salmon dinner finally gets explained(05:56) The "man card" insult that earned a permanent place in the hall of fame(09:07) The case for doing one small thing every single week so you never stop learning